Timing of INR Monitoring When Starting New Medications on Warfarin

Recommended Monitoring Timeline

The American College of Chest Physicians recommends testing INR within 1-2 weeks after any medication change or addition to exclude progressive deviation from the therapeutic range 1
The American College of Chest Physicians suggests that this timeframe allows sufficient time for the new drug interaction to manifest at steady state while preventing prolonged periods of subtherapeutic or supratherapeutic anticoagulation 1

More frequent monitoring may be required during initiation of warfarin therapy or when other drugs that interact with warfarin are started or stopped, as recommended by the American College of Cardiology 2, 3
The 1-2 week interval provides adequate time for the new medication to reach steady state and for any interaction with warfarin to become apparent, according to the American College of Chest Physicians 1
After confirming therapeutic INR following the medication change, continue more frequent monitoring (every 1-2 weeks) until a consistent pattern of stable therapeutic INRs is reestablished before extending intervals back to monthly, as suggested by the American College of Chest Physicians 1

For medications with known significant warfarin interactions, consider checking INR earlier—within 3-7 days, as recommended by the American College of Chest Physicians 1
For minor INR deviations in previously stable patients, the American College of Chest Physicians suggests continuing the current dose and retesting within 1-2 weeks 1

Initial monitoring: Check INR within 1-2 weeks after starting the new medication, as recommended by the American College of Chest Physicians 1
Follow-up monitoring: Test INR 2-3 times weekly for 1-2 weeks after any dose adjustment, then weekly for 1 month, according to the Journal of the American Geriatrics Society 4, 1
Return to baseline: Once stability is reestablished, monitoring can occur every 1-2 months if INR values remain stable, as suggested by the Journal of the American Geriatrics Society 4

More frequent monitoring is indicated during fluctuations in diet and weight, as recommended by the American College of Chest Physicians and the Journal of the American Geriatrics Society 1, 4
More frequent monitoring is indicated during changes in concomitant medications, as recommended by the Journal of the American Geriatrics Society 4
More frequent monitoring is indicated during intercurrent illness, as recommended by the Journal of the American Geriatrics Society 4
More frequent monitoring is indicated during any indication of minor bleeding or changes in baseline INR values, as recommended by the Journal of the American Geriatrics Society 4

Older adults require more vigilant monitoring because they experience an increased risk of hemorrhage and more fluctuations in INR, particularly during illness or medication changes, as recommended by the American College of Chest Physicians 1
In elderly patients, INR should be monitored daily until stable, then two to three times weekly for 1-2 weeks, then weekly for 1 month, and monthly thereafter, as suggested by the American College of Chest Physicians 1

Do not rely on a single INR measurement—continue more frequent monitoring until a pattern of stability is established, as recommended by the American College of Chest Physicians 1